Related Experiment Video
Updated: Jun 8, 2026

Murine Prostate Micro-dissection and Surgical Castration
Published on: May 11, 2016
Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged
Raleigh D Kladney1, Robert D Cardiff, David J Kwiatkowski
1Division of Molecular Oncology, Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri, USA.
Abstract:
The phosphoinositide 3-kinase (PI3K) pathway regulates mammalian cell growth, survival, and motility and plays a major pathogenetic role in human prostate cancer (PCa). However, the oncogenic contributions downstream of the PI3K pathway made by mammalian target of rapamycin complex 1 (mTORC1)-mediated cell growth signal transduction in PCa have yet to be elucidated in detail. Here, we engineered constitutive mTORC1 activation in prostate epithelium by a conditional genetic deletion of tuberous sclerosis complex 1 (Tsc1), a potent negative regulator of mTORC1 signaling. Epithelial inactivation was not immediately tumorigenic, but Tsc1-deficient mice developed prostatic intraepithelial neoplasia (mPIN) in lateral and anterior prostates by 6 months of age, with increasing disease penetrance over time. Lateral prostate lesions in 16- to 22-month-old mutant mice progressed to two types of more advanced lesions, adenomatous gland forming lesion (Type 1) and atypical glands embedded in massively expanded reactive stroma (Type 2). Both Type 1 and Type 2 lesions contained multiple foci of microinvasive carcinoma. Epithelial neoplastic and atypical stromal lesions persisted despite 4 weeks of RAD001 chemotherapy. Rapalogue resistance was not due to AKT or extracellular signal-regulated kinase 1/2 activation. Expression of the homeobox gene Nkx3.1 was lost in Tsc1-deficient mPIN, and it cooperated with TSC1 loss in mPIN initiation in doubly mutant Tsc1:Nkx3.1 prostatic epithelial knockout mice. Thus, TSC1 inactivation distal to PI3K and AKT activation is sufficient to activate a molecular signaling cascade producing prostatic neoplasia and focal carcinogenesis.
Insights
Constitutive activation of mTORC1 signaling by Tsc1 deletion in prostate cells drives prostatic intraepithelial neoplasia and focal carcinogenesis, demonstrating TSC1
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- The phosphoinositide 3-kinase (PI3K) pathway is crucial for cell growth and survival, playing a significant role in prostate cancer (PCa).
- The specific role of mammalian target of rapamycin complex 1 (mTORC1) signaling downstream of PI3K in PCa pathogenesis requires detailed investigation.
Purpose of the Study:
- To elucidate the oncogenic contributions of mTORC1-mediated signaling in prostate cancer.
- To investigate the effects of constitutive mTORC1 activation in prostate epithelium via Tsc1 deletion.
Main Methods:
- Engineered constitutive mTORC1 activation in mouse prostate epithelium by conditional genetic deletion of Tsc1.
- Analyzed lesion progression, histology, and molecular markers in Tsc1-deficient mice.
- Investigated the role of Nkx3.1 in conjunction with Tsc1 loss.
Main Results:
- Tsc1 deletion in prostate epithelium led to prostatic intraepithelial neoplasia (mPIN) and subsequent progression to advanced lesions with microinvasive carcinoma.
- Lesions showed resistance to RAD001 chemotherapy, independent of AKT or ERK1/2 activation.
- Loss of Nkx3.1 expression in Tsc1-deficient mPIN and its cooperative role with TSC1 loss in mPIN initiation were observed.
Conclusions:
- TSC1 inactivation downstream of PI3K and AKT is sufficient to initiate a signaling cascade leading to prostatic neoplasia and carcinogenesis.
- mTORC1 signaling plays a critical role in prostate cancer development and progression.
- Nkx3.1 loss cooperates with TSC1 inactivation in prostate cancer initiation.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Replicative Cell Senescence
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

